Schonfeld Strategic Advisors »

Reneo Pharmaceuticals shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Reneo Pharmaceuticals (RPHM) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Reneo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Reneo Pharmaceuticals held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reneo Pharmaceuticals by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $16k 10k 1.60

More positions owned by Schonfeld Strategic Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
FedEx Corporation (FDX)
Microsoft Corporation (MSFT)
Ishares Msci Brazil Etf Call Option (EWZ)
Ishares Tr U.s. Real Es Etf (IYR)
Mastercard Incorporated Cl A (MA)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Verizon Communications (VZ)
Spdr Ser Tr S&p Biotech (XBI)
Micron Technology (MU)
Johnson Ctls Intl SHS (JCI)

View all positions for Schonfeld Strategic Advisors

Top funds holding Reneo Pharmaceuticals

NEA Management Company
Tang Capital Management
Carlyle
RiverVest Venture Management
Octagon Capital Advisors
BML Capital Management
Ikarian Capital
Highbridge Capital Management
Vanguard Group
Aisling Capital Management
Caption Management
Two Sigma Investments
Millennium Management
LMR Partners
GSA Capital Partners

View all funds holding Reneo Pharmaceuticals